(Total Views: 550)
Posted On: 10/22/2019 6:56:08 PM
Post# of 8403
Medscape - Novel Over-the-Counter Device May Offer Long-Lasting Pain Relief
Damian McNamara
October 22, 2019
A novel, noninvasive, over-the-counter electromagnetic neuromodulation device (ActiPatch, BioElectronics Corp.) appears to deliver long-lasting relief in chronic pain patients. However, at least one pain expert has concerns about the study methodology and interpretation of the results.
Results of a long-term prospective study that included 240 patients who had previously experienced chronic pain relief with the device showed that at 6 months, 97% of the 240 participants sustained 60% reduction in pain. (A short-term study included 682 individuals, and 240 of those people agreed to participate in the longer-term, 6 month study and complete three further assessments.
https://www.medscape.com/viewarticle/920202
Medscape is the leading online global destination for physicians and healthcare professionals worldwide, offering the latest medical news and expert perspectives; essential point-of-care drug and disease information; and relevant professional education and CME.
Damian McNamara
October 22, 2019
A novel, noninvasive, over-the-counter electromagnetic neuromodulation device (ActiPatch, BioElectronics Corp.) appears to deliver long-lasting relief in chronic pain patients. However, at least one pain expert has concerns about the study methodology and interpretation of the results.
Results of a long-term prospective study that included 240 patients who had previously experienced chronic pain relief with the device showed that at 6 months, 97% of the 240 participants sustained 60% reduction in pain. (A short-term study included 682 individuals, and 240 of those people agreed to participate in the longer-term, 6 month study and complete three further assessments.
https://www.medscape.com/viewarticle/920202
Medscape is the leading online global destination for physicians and healthcare professionals worldwide, offering the latest medical news and expert perspectives; essential point-of-care drug and disease information; and relevant professional education and CME.
(1)
(0)
